CD8 T cells specific for human immunodeficiency virus, Epstein-Barr virus, and cytomegalovirus lack molecules for homing to lymphoid sites of infection

Blood

Volumn 98, Issue 1, 2001, Pages 156-164

  Chen, Gang ^a,b,c,d   Shankar, Premlata ^a,b,c,d   Lange, Christoph ^a,b,c,d   Valdez, Hernan ^a,b,c,d   Skolnik, Paul R ^a,b,c,d   Wu, Lijun ^a,b,c,d   Manjunath, N ^a,b,c,d   Lieberman, Judy ^a,b,c,d,e  

^a HARVARD MEDICAL SCHOOL   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MILLENNIUM PHARMACEUTICALS INC   (United States)

^e CENTER FOR BLOOD RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; CHEMOKINE RECEPTOR CCR7; GRANZYME A; PADGEM PROTEIN; PERFORIN;

ANTIGEN SPECIFICITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; EPSTEIN BARR VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOPATHOLOGY; LYMPHOCYTE DIFFERENTIATION; LYMPHOID TISSUE; MAJOR HISTOCOMPATIBILITY COMPLEX; MEMORY CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; T LYMPHOCYTE; TISSUE DISTRIBUTION;

EID: 0035412370     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V98.1.156     Document Type: Article

References (54)

1. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 1994;76:301-314.
2. Butcher EC, Picker LJ. Lymphocyte homing and homeostasis. Science. 1996;272:60-66.
3. Nakano H, Mori S, Yonekawa H, Nariuchi H, Matsuzawa A, Kakiuchi T. A novel mutant gene involved in T-lymphocyte-specific homing into peripheral lymphoid organs on mouse chromosome 4. Blood. 1998;91:2886-2895.
4. Forster R, Schubel A, Breitfeld D, et al. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell. 1999;99:23-33.
5. Stein JV, Rot A, Luo Y, et al. The CC chemokine thymus-derived chemotactic agent 4 (TCA-4, secondary lymphoid tissue chemokine, 6Ckine, exodus-2) triggers lymphocyte function-associated antigen 1-mediated arrest of rolling T lymphocytes in peripheral lymph node high endothelial venules. J Exp Med. 2000;191:61-76.
6. Campbell JJ, Bowman EP, Murphy K, et al. 6-C-kine (SLC), a lymphocyte adhesion-triggering chemokine expressed by high endothelium, is an agonist for the MIP-3β receptor CCR7. J Cell Biol. 1998;141:1053-1059.
7. Tangemann K, Gunn MD, Giblin P, Rosen SD. A high endothelial cell-derived chemokine induces rapid, efficient, and subset-selective arrest of rolling T lymphocytes on a reconstituted endothelial substrate. J Immunol. 1998;161:6330-6337.
8. Mackay CR, Marston WL, Dudler L. Naive and memory T cells show distinct pathways of lymphocyte recirculation. J Exp Med. 1990;171:801-817.
9. Vitetta ES, Berton MT, Burger C, Kepron M, Lee WT, Yin XM. Memory B and T cells. Annu Rev Immunol. 1991;9:193-217.
10. Gray D. Immunological memory. Annu Rev Immunol. 1993;11:49-77.
11. Swain SL, Croft M, Dubey C, et al. From naïve to memory T cells. Immunol Rev. 1996;150:143-167.
12. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature. 1999;401:708-712.
13. + T cells. J Exp Med. 1997;186:1407-1418.
14. Walker BD, Chakrabarti S, Moss B, et al. HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature. 1987;328:345-348.
15. Plata F, Autran B, Martins LP, et al. AIDS virus-specific cytotoxic T lymphocytes in lung disorders. Nature. 1987;328:348-351.
16. Hoffenbach A, Langlade-Demoyen P, Dadaglio G, et al. Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans. J Immunol. 1989;142:452-462.
17. Altman JD, Moss PAH, Goulder PJR, et al. Phenotypic analysis of antigen-specific T lymphocytes. Science. 1996;274:94-96.
18. + T cells in HIV-infected progressors and long-term nonprogressors. J Immunol. 2000;165:1082-1092.
19. Lieberman J. Cytotoxic T lymphocyte adoptive immunotherapy for HIV infection. In: Sitkovsky MV, Henkart PA, eds. Cytotoxic cells: Basic Mechanisms and Medical Applications. Philadelphia, PA: Lippincott Williams and Wilkins; 1999:441-457.
20. Roederer M, De Rosa S, Gerstein R, et al. Eight-color, 10-parameter flow cytometry to elucidate complex leukocyte heterogeneity. Cytometry. 1997;29:328-339.
21. Andersson J, Behbahani H, Lieberman J, et al. Perforin is not co-expressed with granzyme A within cytotoxic granules in CD8 T lymphocytes present in lymphoid tissue during chronic HIV infection. AIDS. 1999;13:1295-1303.
22. + T cells in chronic human immunodeficiency virus infection. Blood. 2000;96:3094-3101.
23. Johnson RP, Trocha A, Yang L, et al. HIV-1 gag-specific cytotoxic T lymphocytes recognize multiple highly conserved epitopes: fine specificity of the gag-specific response defined by using unstimulated peripheral blood mononuclear cells and cloned effector cells. J Immunol. 1991;147:1512-1521.
24. Ogg GS, Jin X, Bonhoeffer S, et al. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science. 1998;279:2103-2106.
25. Walker BD, Flexner C, Paradis TJ, et al. HIV-1 reverse transcriptase is a target for cytotoxic T lymphocytes in infected individuals. Science. 1988;240:64-66.
26. Shankar P, Fabry JA, Fong DM, Lieberman J. Three regions of HIV-1 gp160 contain clusters of immunodominant CTL epitopes. Immunol Lett. 1996;52:23-30.
27. Wills MR, Carmichael AJ, Mynard K, et al. The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL. J Virol. 1996;70:7569-7579.
28. + T lymphocytes using MHC tetramers in kidney transplant patients and healthy participants. Transplantation. 2000;69:2243-2250.
29. Singhal S, Shaw JC, Ainsworth J, et al. Direct visualization and quantitation of cytomegalovirus-specific CD8+ cytotoxic T-lymphocytes in liver transplant patients. Transplantation. 2000;69:2251-2259.
30. Steven NM, Annels NE, Kumar A, et al. Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response. J Exp Med. 1997;185:1605-1617.
31. + T cells during the primary immune response to Epstein-Barr virus in vivo. J Exp Med. 1998;187:1395-1402.
32. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Centers for Disease Control. MMWR Morb Mortal Wkly Rep. 1993;41:1-19.
33. Roederer M, Dubs JG, Anderson MT, Raju PA, Herzenberg LA. CD8 naive T cell counts decrease progressively in HIV-infected adults. J Clin Invest. 1995;95:2061-2066.
34. Garcia-Sanz JA, Velotti F, MacDonald HR, Masson D, Tschopp J, Nabholz M. Appearance of granule-associated molecules during activation of cytotytic T-lymphocyte precursors by defined stimuli. Immunology. 1988;64:129-134.
35. Trimble LA, Lieberman J. Circulating CD8 T lymphocytes in human immunodeficiency virus-infected individuals have impaired function and downmodulate CD3ζ, the signaling chain of the T-cell receptor complex. Blood. 1998;91:585-594.
36. Lieberman J, Fabry JA, Fong DM, Parkerson GR 3rd. Recognition of a small number of diverse epitopes dominates the cytotoxic T lymphocytes response to HIV type 1 in an infected individual. AIDS Res Hum Retroviruses. 1997;13:383-392.
37. Warnock RA, Campbell JJ, Dorf ME, Matsuzawa A, McEvoy LM, Butcher EC. The role of chemokines in the microenvironmental control of T versus B cell arrest in Peyer's patch high endothelial venules. J Exp Med. 2000;191:77-88.
38. Kuroda MJ, Schmitz JE, Charini WA, et al. Emergence of CTL coincides with clearance of virus during primary simian immunodeficiency virus infection in rhesus monkeys. J Immunol. 1999;162:5127-5133.
39. Brodie SJ, Lewinsohn DA, Patterson BK, et al. In vivo migration and function of transferred HIV-1-specific cytotoxic T cells. Nature Med. 1999;5:34-41.
40. + T cells produce antiviral cytokines but are impaired in cytolytic function. J Exp Med. 2000;192:63-75.
41. - human T cells. J Immunol. 2000;165:1910-1917.
42. + T cells closely correlates with CD56 surface expression. J Immunol. 2000;164:1148-1152.
43. Kagi D, Ledermann B, Burki K, et al. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature. 1994;369:31-37.
44. Shankar P, Xu Z, Lieberman J. Viral-specific cytotoxic T lymphocytes lyse HIV-infected primary T lymphocytes by the granule exocytosis pathway. Blood. 1999;94:3084-3093.
45. Collins KL, Chen BK, Kalams SA, Walker BD, Baltimore D. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature. 1998;391:397-401.
46. Phillips RE, McMichael AJ. How does the HIV escape cytotoxic T cell immunity? Chem Immunol. 1993;56:150-164.
47. - cell population in the blood and lung of HIV-positive patients. J Acquir Immune Defic Syndr. 1993;6:1194-1204.
48. - T cells. Acta Chem Scand. 1994;8:431-441.
49. + T cells from HIV-infected persons. J Immunol. 1994;153:412-420.
50. Stefanova I, Saville MW, Peters C, et al. HIV infection-induced posttranslational modification of T cell signaling molecules associated with disease progression. J Clin Invest. 1996;98:1290-1297.
51. Geertsma MF, van Wengen-Stevenhagen A, van Dam EM, et al. Decreased expression of ζ molecules by T lymphocytes is correlated with disease progression in human immunodeficiency virus-infected persons. J Infect Dis. 1999;180:649-658.
52. Trimble LA, Shankar P, Patterson M, Daily JP, Lieberman J. Human immunodeficiency virus-specific circulating CD8 T lymphocytes have down-modulated CD3ζ and CD28, key signaling molecules for T-cell activation. J Virol. 2000;74:7320-7330.
53. De Maria A, Ferraris A, Guastella M, Pilla S, et al. Expression of HLA class I-specific inhibitory natural killer cell receptors in HIV-specific cytolytic T lymphocytes: impairment of specific cytolytic functions. Proc Natl Acad Sci U S A. 1997;94:10285-10288.
54. Trimble LA, Kam LW, Friedman RS, Xu Z, Lieberman J. CD3ζ and CD28 down-modulation on CD8 T cells during viral infection. Blood. 2000;96:1021-1029.